Volume 93, Issue S255
ABS15-0027
Free Access

Update on treatment strategies for LHON

P. Yu-Wai-Man

P. Yu-Wai-Man

Institute of Genetic Medicine, Newcastle University, Wellcome Trust Centre for Mitochondrial Research, Newcastle upon Tyne, United Kingdom

Search for more papers by this author
First published: 23 September 2015

Summary

Leber hereditary optic neuropathy (LHON) is an important cause of severe bilateral visual loss among young adults. This presentation will review the evidence base for the various treatment strategies that have been put forward to treat this mitochondrial disorder, including future developments. Innovative IVF techniques to prevent the maternal transmission of pathogenic mitochondrial DNA mutations will also be discussed.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.